Table 4. Factors associated with metastatic disease.
| Seminomas | NSGCT | |||||
|---|---|---|---|---|---|---|
| Univariate | Multivariate | Univariate | Multivariate | |||
| p-value | p-value | OR (95% CI) | p-value | p-value | OR (95% CI) | |
| Size >4 cm | 0.936 | 0.831 | 0.566 | 0.677 | ||
| T staging | 0.011 | 0.038 | 3.81 (1.78–5.64) | <0.01 | 0.174 | |
| S staging | 0.232 | 0.553 | <0.01 | 0.150 | ||
| NLR ≥3.0 | 0.024 | 0.041 | 2.48 (1.22–3.98) | <0.01 | 0.043 | 2.21 (1.17–3.65) |
| Nodal disease | <0.01 | <0.01 | 11.18 (8.42–18.46) | <0.01 | 0.028 | 9.68 (5.32–14.58) |
NSGCT, non-seminomatous germ cell tumour; OR, odds ratio; CI, confidence interval; NLR, neutrophil-to-lymphocyte ratio.